This company has been marked as potentially delisted and may not be actively trading. Karuna Therapeutics (KRTX) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Karuna Therapeutics Short Interest DataKaruna Therapeutics (KRTX) has a short interest of 1.97 million shares. This marks a -6.64% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 832,048 shares to cover all short positions.Current Short Interest1,970,000 sharesPrevious Short Interest2,110,000 sharesChange Vs. Previous Month-6.64%Dollar Volume Sold Short$618.52 millionShort Interest Ratio2.3 Days to CoverLast Record DateFebruary 29, 2024Outstanding Shares38,148,000 sharesPercentage of Shares Shorted5.16%Today's Trading Volume5 sharesAverage Trading Volume832,048 sharesToday's Volume Vs. Average0% Short Selling Karuna Therapeutics? Sign up to receive the latest short interest report for Karuna Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRTX Short Interest Over TimeKRTX Days to Cover Over TimeKRTX Percentage of Float Shorted Over Time Karuna Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,970,000 shares $618.52 million -6.6%N/A2.3 $313.97 2/15/20242,110,000 shares $673.91 million +24.9%N/A2.5 $319.39 1/31/20241,690,000 shares $529.68 million +15.8%N/A2.1 $313.42 1/15/20241,460,000 shares $462.46 million -4.6%N/A2 $316.75 12/31/20231,530,000 shares $484.26 million -24.3%N/A2.5 $316.51 12/15/20232,020,000 shares $443.94 million -1.5%N/A4.7 $219.77 11/30/20232,050,000 shares $391.98 million +7.3%N/A7.7 $191.21 11/15/20231,910,000 shares $328.06 million +3.8%N/A8.1 $171.76 10/31/20231,840,000 shares $306.56 million +12.2%N/A7.7 $166.61 10/15/20231,640,000 shares $280.46 million -1.8%N/A6.5 $171.01 Get the Latest News and Ratings for KRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Karuna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 9/30/20231,670,000 shares $282.38 million +18.4%N/A6.6 $169.09 9/15/20231,410,000 shares $255.07 million +4.4%N/A5.3 $180.90 8/31/20231,350,000 shares $253.48 million -6.9%N/A3.9 $187.76 8/15/20231,450,000 shares $260.26 million +16.0%N/A4 $179.49 7/31/20231,250,000 shares $249.71 million -1.6%N/A3.3 $199.77 7/15/20231,270,000 shares $269.01 million -4.5%N/A3.3 $211.82 6/30/20231,330,000 shares $288.41 million -37.0%N/A3.3 $216.85 6/15/20232,110,000 shares $503.34 million -0.9%N/A5 $238.55 5/31/20232,130,000 shares $482.55 million +2.4%N/A5.2 $226.55 5/15/20232,080,000 shares $479.69 million -2.4%N/A5 $230.62 4/30/20232,130,000 shares $422.68 million +1.4%N/A5.1 $198.44 4/15/20232,100,000 shares $383.54 million -1.9%N/A5.2 $182.64 3/31/20232,140,000 shares $388.71 million +22.3%N/A5.5 $181.64 3/15/20231,750,000 shares $327.37 million +0.6%N/A4.8 $187.07 2/28/20231,740,000 shares $346.99 million +4.2%6.1%5.8 $199.42 2/15/20231,670,000 shares $324.23 million No Change5.9%5.8 $194.15 1/31/20231,670,000 shares $332.98 million -0.6%6.0%5.8 $199.39 1/15/20231,680,000 shares $337.26 million -2.9%6.0%5.7 $200.75 12/30/20221,730,000 shares $339.95 million +10.9%6.3%5.8 $196.50 12/15/20221,560,000 shares $312 million +6.1%5.6%4.8 $200.00 11/30/20221,470,000 shares $345.91 million -13.5%5.4%4.1 $235.31 11/15/20221,700,000 shares $392.31 million +4.9%6.2%4.8 $230.77 10/31/20221,620,000 shares $355.33 million No Change6.2%3.6 $219.34 10/15/20221,620,000 shares $333.56 million +14.9%6.4%3 $205.90 9/30/20221,410,000 shares $317.15 million -23.4%5.6%2.7 $224.93 9/15/20221,840,000 shares $449.07 million -1.1%7.3%3.5 $244.06 8/31/20221,860,000 shares $474.41 million -9.7%7.6%3.6 $255.06 8/15/20222,060,000 shares $563.84 million +36.4%8.4%4.2 $273.71 7/31/20221,510,000 shares $196.68 million +6.3%7.0%3.8 $130.25 7/15/20221,420,000 shares $191.97 million +5.2%6.6%4.7 $135.19Generate up to $5,000/month with 10X less money? (Ad)The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly income to cover housing, healthcare, food, and fun... With a fraction of what you probably think you need.Here's the secret to retiring without a million-dollar nest egg → 6/30/20221,350,000 shares $170.79 million +13.5%6.2%4.5 $126.51 6/15/20221,190,000 shares $122.52 million +19.0%5.5%4.4 $102.96 5/31/20221,000,000 shares $104.32 million +1.6%4.6%4.3 $104.32 5/15/2022984,700 shares $102.31 million -3.5%4.5%4.3 $103.90 4/30/20221,020,000 shares $113.69 million -1.0%4.7%4.6 $111.46 4/15/20221,030,000 shares $141.83 million +6.6%4.8%5.1 $137.70 3/31/2022966,000 shares $122.48 million +7.8%4.5%4.6 $126.79 3/15/2022896,400 shares $93.99 million +8.1%N/A4.5 $104.85 2/28/2022829,200 shares $87.07 million -14.3%3.8%4.1 $105.00 2/15/2022967,700 shares $108.39 million -2.6%4.5%4.7 $112.01 1/31/2022993,500 shares $110.34 million -16.5%4.6%5.3 $111.06 1/15/20221,190,000 shares $148.12 million +0.9%5.5%6.6 $124.47 12/31/20211,180,000 shares $154.58 million -11.9%5.5%7.2 $131.00 12/15/20211,340,000 shares $156.93 million -2.9%6.2%8.6 $117.11 11/30/20211,380,000 shares $176.50 million -6.1%6.4%9.7 $127.90 11/15/20211,470,000 shares $198.76 million -13.0%6.9%11.1 $135.21 10/29/20211,690,000 shares $237.24 million +1.2%8.2%14.4 $140.38 10/15/20211,670,000 shares $206.70 million No Change8.0%13.9 $123.77 9/30/20211,670,000 shares $204.29 million No Change8.0%12.4 $122.33 9/15/20211,670,000 shares $191.60 million -11.2%7.9%10.2 $114.73 8/31/20211,880,000 shares $223.53 million No Change8.9%10.8 $118.90 8/13/20211,880,000 shares $200.84 million -6.9%8.9%10.6 $106.83 7/30/20212,020,000 shares $230.72 million +4.1%9.6%11.4 $114.22 7/15/20211,940,000 shares $218.89 million +1.0%9.2%11.5 $112.83 6/30/20211,920,000 shares $218.86 million +1.6%9.1%11.5 $113.99 6/15/20211,890,000 shares $239.84 million -3.1%9.0%12.9 $126.90 5/28/20211,950,000 shares $218.05 million +6.6%9.3%12.8 $111.82 5/14/20211,830,000 shares $211.79 million +10.2%8.7%9.9 $115.73 4/30/20211,660,000 shares $183.45 million -1.8%8.0%8.2 $110.51 4/15/20211,690,000 shares $195.09 million -3.4%8.2%7.8 $115.44 3/31/20211,750,000 shares $204.54 million +5.4%8.9%8.3 $116.88 3/15/20211,660,000 shares $198.27 million +8.5%8.4%7.7 $119.44 2/26/20211,530,000 shares $184.84 million +4.8%7.8%7.8 $120.81 2/12/20211,460,000 shares $172.00 million +14.1%8.1%9 $117.81 1/29/20211,280,000 shares $126.18 million +2.4%7.1%7.8 $98.58 1/15/20211,250,000 shares $126.06 million -12.6%7.0%8.3 $100.85 12/31/20201,430,000 shares $148.18 million -4.0%8.1%9.8 $103.62 12/15/20201,490,000 shares $140.78 million -8.0%8.4%9.6 $94.48 11/30/20201,620,000 shares $162 million -8.0%9.1%9.7 $100.00 11/15/20201,760,000 shares $169.24 million +8.0%10.0%9.4 $96.16 10/30/20201,630,000 shares $131.56 million +2.5%9.3%9.1 $80.71 10/15/20201,590,000 shares $127.92 million +2.6%9.1%9.5 $80.45 9/30/20201,550,000 shares $119.85 million +14.0%8.9%9 $77.32 9/15/20201,360,000 shares $113.89 million -7.5%7.8%7.2 $83.74 8/31/20201,470,000 shares $112.31 million -11.5%8.4%7.2 $76.40 KRTX Short Interest - Frequently Asked Questions What is Karuna Therapeutics' current short interest? Short interest is the volume of Karuna Therapeutics shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 1,970,000 shares of KRTX short. Learn More on Karuna Therapeutics' current short interest. What is a good short interest ratio for Karuna Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRTX shares currently have a short interest ratio of 2.0. Learn More on Karuna Therapeutics's short interest ratio. Is Karuna Therapeutics' short interest increasing or decreasing? Karuna Therapeutics saw a drop in short interest in February. As of February 29th, there was short interest totaling 1,970,000 shares, a drop of 6.6% from the previous total of 2,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Karuna Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Karuna Therapeutics: Zymeworks Inc. (3.24%), Aerovate Therapeutics, Inc. (21.72%), PyroGenesis Canada Inc. (0.16%), Actinium Pharmaceuticals, Inc. (2.68%), Aadi Bioscience, Inc. (6.58%), Eagle Pharmaceuticals, Inc. (0.46%), NanoViricides, Inc. (0.57%), AEON Biopharma, Inc. (3.71%), Matinas Biopharma Holdings, Inc. (1.05%), Spruce Biosciences, Inc. (0.22%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors Company ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Corporation ($3.13 billion), Tractor Supply Company ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Karuna Therapeutics stock? Short selling KRTX is an investing strategy that aims to generate trading profit from Karuna Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Karuna Therapeutics? A short squeeze for Karuna Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KRTX, which in turn drives the price of the stock up even further. How often is Karuna Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRTX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies Zymeworks Short Interest Aerovate Therapeutics Short Interest PyroGenesis Canada Short Interest Actinium Pharmaceuticals Short Interest Aadi Bioscience Short Interest Eagle Pharmaceuticals Short Interest NanoViricides Short Interest AEON Biopharma Short Interest Matinas Biopharma Short Interest Spruce Biosciences Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRTX) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Karuna Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Karuna Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access